NDC62135-0717-26 — CHLOROQUINE PHOSPHATE TABLETS

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC62135-0717-26: CHLOROQUINE PHOSPHATE TABLETS.

The CHLOROQUINE PHOSPHATE TABLETS is a the manufacturer industrial component. Key specifications include primary_container_type: BOTTLE, therapeutic_equivalent: ARALEN BY SANOFI/WINTHROP PHARM., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 25.000 TABLETS, active_medicament_medicinal_strength: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-267-9662, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC62135-0717-26

NSN: 6505-01-267-9662
FSC: 6505 — Drugs and Biologicals
CAGE: 8APG0 — CHARTWELL RX LLC (USA)

SPECIFICATIONS

primary_container_type	BOTTLE
therapeutic_equivalent	ARALEN BY SANOFI/WINTHROP PHARM.
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
primary_container_content_quantity	25.000 TABLETS
active_medicament_medicinal_strength	500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
NSN	6505-01-267-9662

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: ARALEN BY SANOFI/WINTHROP PHARM.

•

PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	ARALEN BY SANOFI/WINTHROP PHARM.
PRIMARY CONTAINER CONTENT QUANTITY	25.000 TABLETS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
PART NAME ASSIGNED BY CONTROLLING AGENCY	CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 2

NDC64980-0178-02Reference document

Same NSN cross-reference

Reference document — Secondary reference

NDC00143-2125-22Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC62135-0717-26?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC62135-0717-26?

NDC62135-0717-26 is a CHLOROQUINE PHOSPHATE TABLETS.

What parts can replace NDC62135-0717-26?

There are 2 known substitutes for NDC62135-0717-26: NDC64980-0178-02, NDC00143-2125-22. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC62135-0717-26?

NDC62135-0717-26 is cataloged in the U.S. Government catalog under NSN 6505-01-267-9662. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC62135-0717-26 — CHLOROQUINE PHOSPHATE TABLETS

Request a Quote — NDC62135-0717-26